Programa sobre Trastorno Bipolar del 26 ECNP Barcelona 2013

198 views
134 views

Published on

Programa sobre Trastorno Bipolar del 26 ECNP Barcelona 2013
Más información en www.puedoser.es

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
198
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Programa sobre Trastorno Bipolar del 26 ECNP Barcelona 2013

  1. 1. C.03: Prioritising the patient in the management ofmajor depressive disorderEducational financial support provided by AstraZenecaSaturday 15:45 - 17:30Room: Room HChairKoen Demyttenaere, BelgiumPresentationsC.03.01: How confidently can we predict response in patients with MDD?Philip Gorwood, FranceC.03.02: From hopelessness to hope: a patient-centred approachHamish McAllister-Williams, United KingdomC.03.03: New pharmacotherapeutic opportunities for the treatment ofdepressionBrian Leonard, IrelandSession TypeSatellite symposiumC.08: Bipolar disorder: the evolving storyEducational financial support provided by AstraZenecaSunday 16:45 - 18:30Room: Room JChairRoger McIntyre, CanadaPresentationsC.08.01: Improving patient outcomes in bipolar disorderEduard Vieta, SpainC.08.02: A disease for life? Beyond acute episodes in bipolar disorderGuy Goodwin, United KingdomSession TypeSatellite symposiumC.13: The multidimensional perspective of Bipolar IdisorderMonday 16:45 - 18:30Room: Room M2ChairAndrea Fagiolini, ItalyPresentations
  2. 2. C.13.01: The manic depressive spectrum, the DSM5 perspectiveAndrea Fagiolini, ItalyC.13.02: Bipolar mixed states, recognition and courseAllan H. Young, United KingdomC.13.03: Treatment of mixed statesMichael Berk, AustraliaSession TypeSatellite symposiumS.25: Genetic implications in bipolar disorderWednesday 09:00 - 10:40Room: AuditoriumChairIstván Bitter, HungaryPresentations09:00-09:25S.25.01: Pharmacogenetics of antidepressant, antiepileptic and neurolepticdrug treatmentLeif Bertilsson, Sweden09:25-09:50S.25.02: Molecular genetic aspects to serotonergic drugs in bipolar disorderXenia Gonda, Hungary09:50-10:15S.25.03: Pharmacogenetics of efficacy and treatment side effects in bipolardisorderAlessandro Serretti, Italy10:15-10:40S.25.04: Genetics of suicidal behaviour in bipolar disorder: an updateAntoni Benabarre, SpainSession TypeSymposiumTrackClinical Treatment trackS.25: Genetic implications in bipolar disorderWednesday 09:00 - 10:40Room: AuditoriumChairIstván Bitter, HungaryPresentations09:00-09:25S.25.01: Pharmacogenetics of antidepressant, antiepileptic and neurolepticdrug treatmentLeif Bertilsson, Sweden09:25-09:50S.25.02: Molecular genetic aspects to serotonergic drugs in bipolar disorder
  3. 3. Xenia Gonda, Hungary09:50-10:15S.25.03: Pharmacogenetics of efficacy and treatment side effects in bipolardisorderAlessandro Serretti, Italy10:15-10:40S.25.04: Genetics of suicidal behaviour in bipolar disorder: an updateAntoni Benabarre, Spain

×